Trial hold delays Concert in race for first alopecia treatment

18 May 2017
2019_biotech_test_vial_discovery_big

Shares in USA-based Concert Pharmaceuticals (Nasdaq: CNCE) dropped 10% before rallying slightly, as stockholders learned the company’s clinical trial into hair loss candidate CTP-543 has been put on hold by the US Food and Drug Administration.

The news came as the company was preparing to dose subjects in the Phase IIa trial. Now Concert will have to wait for the agency to review certain “recently completed non-clinical toxicology studies.”

The company notes that the FDA did not cite a safety concern. It will submit the requested non-clinical study reports promptly, which will be reviewed in respect of the planned one-year dosing duration.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Biotechnology